Walleye Trading
NDRM

Walleye Trading’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Walleye Trading’s Portfolio NDRM Stock Details NDRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,200
Closed -$20K – 6017
2016
Q2 		$20K Buy
+1,200
New +$20.2K ﹤0.01% 4571

Other funds holding NDRM

VOAM
Vertex One Asset Management Vancouver, British Columbia, Canada $434M AUM 37.82% 1-Year Est. Return
OTC
Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return

Walleye Trading's NDRM Position: Q3 2016 in Review

Walleye Trading sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q3 2016, closing a stake of 1,200 shares — an estimated $20K sold.

Walleye Trading first reported a position in NDRM in Q2 2016 and held it in 1 quarter. The position peaked at $20K in Q2 2016. 50 funds tracked by Wall St. Rank hold NDRM as of Q3 2016.

  • Walleye Trading reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q3 2016 after selling out during the quarter.
  • Walleye Trading sold 1,200 NeuroDerm Ltd. Ordinary Shares shares in Q3 2016, an estimated $20K.
  • Walleye Trading first reported a position in NeuroDerm Ltd. Ordinary Shares in Q2 2016 and held it in 1 quarter.
  • Walleye Trading's NeuroDerm Ltd. Ordinary Shares position peaked at $20K in Q2 2016.
  • 50 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q3 2016.

Based on Walleye Trading's 13F filing for Q3 2016, filed 14 Nov 2016.